Quality of life in chronic myeloid leukemia care
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how chronic myeloid leukemia (CML) affects your daily life and how care is organized in Lombardy hospitals. Researchers want to learn from your experiences to improve care for everyone with CML.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with chronic myeloid leukemia (CML).
- You are being treated at one of the 21 REL hematology clinics in Lombardy.
- You have been followed at that center for at least 6 months.
- You agree to take part in the study by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a real-life study that collects information from people living with chronic myeloid leukemia (CML). It may help doctors understand how CML treatments are used in practice and how well they work over time.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study looks at how multiple myeloma and its treatment affect the daily life, well-being, and social activities of patients and their caregivers. It aims to understand what factors influence their quality of life.
This study looks at what it’s like to live with chronic lymphocytic leukemia while participating in a clinical research protocol. It may help researchers understand patient experiences and improve how future trials are run.
This research study examines blood cells from patients with chronic myelomonocytic leukemia (CMML), a rare blood cancer, to better understand how the disease develops and progresses. By studying your blood cells, researchers hope to learn more about what causes CMML and how to treat it better.
This research study collects information from adults with chronic myelomonocytic leukemia (CMML), a rare blood cancer where the body makes too many monocytes (a type of white blood cell). By following patients over time, researchers aim to better understand the disease and improve treatments.
Hear when a new Chronic Myeloid Leukemia (CML) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.